MPWT
AVBP icon

MassMutual Private Wealth & Trust’s ArriVent BioPharma AVBP Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$764 Buy
+22
New +$649 ﹤0.01% 2219

Other funds holding AVBP

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
TM
Torren Management San Diego, California $197M AUM

MassMutual Private Wealth & Trust's AVBP Position: Q2 2026 in Review

MassMutual Private Wealth & Trust opened a new position in ArriVent BioPharma (AVBP) in Q2 2026: 22 shares worth $764. The stake represents ﹤0.01% of the portfolio and ranks #2219 among its holdings.

9 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • MassMutual Private Wealth & Trust held 22 shares of ArriVent BioPharma worth $764 as of Q2 2026.
  • ArriVent BioPharma was a new MassMutual Private Wealth & Trust position in Q2 2026.
  • ArriVent BioPharma made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #2219 holding.
  • 9 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.